EW icon

Edwards Lifesciences
EW

Overview Fund Activity

920 hedge funds and large institutions have $32B invested in Edwards Lifesciences in 2019 Q2 according to their latest regulatory filings, with 95 funds opening new positions, 295 increasing their positions, 357 reducing their positions, and 83 closing their positions.

Holders
920
Holders Change
-1
Holders Change %
-0.11%
% of All Funds
20.01%
Holding in Top 10
21
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-16%
% of All Funds
0.46%
New
95
Increased
295
Reduced
357
Closed
83
Calls
$224M
Puts
$169M
Net Calls
+$55.7M
Net Calls Change
+$28.2M

Top Buyers

1
Nuveen Asset Management
1
Nuveen Asset Management
Illinois
$730M
2
Capital International Investors
2
Capital International Investors
California
$518M
3
Capital Research Global Investors
3
Capital Research Global Investors
California
$945M
4
HM
4
HealthCor Management
New York
$115M
5
Bessemer Group
5
Bessemer Group
New Jersey
$93M

Top Sellers

1
Vanguard Group
1
Vanguard Group
Pennsylvania
$2.95B
2
Wellington Management Group
2
Wellington Management Group
Massachusetts
$889M
3
BlackRock
3
BlackRock
New York
$3.05B
4
VOYA Investment Management
4
VOYA Investment Management
Georgia
$15.4M
5
American Century Companies
5
American Century Companies
Missouri
$235M
Name Market Value Shares Shares
Change 		Shares
Change %
Legal & General Group
26
Legal & General Group
United Kingdom
$238M 3,866,706 -25,224 -0.6%
American Century Companies
27
American Century Companies
Missouri
$235M 3,819,096 -1,824,585 -32%
Wells Fargo
28
Wells Fargo
California
$229M 3,714,498 +381,480 +11%
Invesco
29
Invesco
Georgia
$202M 3,283,830 +455,058 +16%
Thrivent Financial for Lutherans
30
Thrivent Financial for Lutherans
Minnesota
$195M 3,163,635 +31,743 +1%
Morgan Stanley
31
Morgan Stanley
New York
$185M 3,010,530 +421,599 +16%
AQR Capital Management
32
AQR Capital Management
Connecticut
$180M 2,925,462 +204,942 +8%
Charles Schwab
33
Charles Schwab
California
$178M 2,885,847 -67,410 -2%
UBS AM
34
UBS AM
Illinois
$172M 2,800,839 +221,559 +9%
CIP
35
Champlain Investment Partners
Vermont
$152M 2,469,705 +286,005 +13%
UBS Group
36
UBS Group
Switzerland
$151M 2,448,603 -146,772 -6%
Sumitomo Mitsui Trust Group
37
Sumitomo Mitsui Trust Group
Japan
$150M 2,436,234 -56,151 -2%
Barclays
38
Barclays
United Kingdom
$149M 2,427,744 +868,389 +56%
Neuberger Berman Group
39
Neuberger Berman Group
New York
$148M 2,407,953 -101,448 -4%
CIBC Private Wealth Group
40
CIBC Private Wealth Group
Georgia
$136M 2,205,630 -70,671 -3%
O
41
OrbiMed
New York
$132M 2,145,000 – –
WRF
42
Waddell & Reed Financial
Kansas
$132M 2,136,540 -70,182 -3%
Swiss National Bank
43
Swiss National Bank
Switzerland
$125M 2,033,994 -59,100 -3%
FCM
44
Frontier Capital Management
Massachusetts
$119M 1,933,761 -214,863 -10%
PPA
45
Parametric Portfolio Associates
Washington
$119M 1,925,598 -2,979 -0.2%
HM
46
HealthCor Management
New York
$115M 1,866,690 +1,866,690 New
Artisan Partners
47
Artisan Partners
Wisconsin
$112M 1,812,339 -237,237 -12%
Citadel Advisors
48
Citadel Advisors
Florida
$107M 1,741,434 -708,774 -29%
AC
49
AKO Capital
United Kingdom
$105M 1,710,762 +335,709 +24%
Deutsche Bank
50
Deutsche Bank
Germany
$99.5M 1,615,998 -55,989 -3%
1
2
3 4 5